Servier Laboratories Limited
Servier Laboratories Limited, a prominent player in the global pharmaceutical industry, is headquartered in Great Britain. Founded in 1954, the company has established a strong presence in various operational regions, including Europe, Africa, and Asia. Specialising in innovative treatments, Servier focuses on key therapeutic areas such as cardiovascular diseases, diabetes, and oncology. With a commitment to research and development, Servier is known for its unique approach to drug formulation and patient care. The company’s core products, including well-regarded medications like Perindopril, exemplify its dedication to improving health outcomes. Servier's notable achievements include a robust pipeline of new therapies and a reputation for quality and reliability in the pharmaceutical market, solidifying its position as a trusted name in healthcare.
DitchCarbon Score
How does Servier Laboratories Limited's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Servier Laboratories Limited's score of 28 is higher than 50% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Servier Laboratories Limited's reported carbon emissions
Servier Laboratories Limited, headquartered in Great Britain, currently does not have publicly available data on its carbon emissions, as no specific emissions figures have been provided. Additionally, there are no documented reduction targets or climate pledges outlined in their initiatives. This lack of information suggests that the company may still be in the early stages of formalising its climate commitments or reporting on its emissions. In the pharmaceutical industry, companies are increasingly focusing on sustainability and reducing their carbon footprints, so it will be important for Servier to establish clear targets and strategies in line with industry standards to address climate change effectively.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Servier Laboratories Limited is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
